5AM Ventures

Venture Capital Firm

5AM Ventures

5AM Ventures

5AM Ventures

MVCA Member

5AM’s portfolio of advanced life science technologies is diversified within the healthcare industry’s biopharmaceutical, medical, technology, and research instrument sectors. Within each sector, 5AM evaluates innovative platform technologies, corporate spin-offs and products with shorter development cycles and invests across multiple therapeutic areas.



  • Andrew J. Schwab
    Managing Partner
  • John D. Diekman PHD
    Managing Partner
  • Scott M. Rocklage PHD
    Managing Partner
  • Kush Parmar
    Managing Partner
  • Britt Inga Emerson
    Executive Assistant

Stages of Investment

  • Seed

Sectors of Investment

  • n/a

IT Subsectors

Life Science Subsectors

  • Biotechnology
  • Diagnostics
  • Pharmaceuticals


  • Assets Under Management $685,000,000

The most timely & relevant email you will get about Michigan’s investment & entrepreneurial ecosystem.

From public policy to the new ideas and breakthrough investment opportunities, MVCA will keep your finger on the pulse of must know information in the industry.


This field is for validation purposes and should be left unchanged.